Laura Cànaves-Gómez

Laura Cànaves-Gómez


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LMLluc Riera Martínez
Lluc Riera Martínez
LCLaura Cànaves-Gómez
Laura Cànaves-Gómez
AIAmanda Iglesias
Amanda Iglesias
AMAina Martin-Medina
Aina Martin-Medina
Borja G CosíoBorja G Cosío
Borja G Cosío
COPD is a leading cause of mortality and morbidity worldwide and is associated with a high socioeconomic burden. Current treatment includes the use of inhaled corticosteroids and bronchodilators, which can help to improve symptoms and reduce exacerbations; however, there is no solution for restoring lung function and the emphysema caused by loss of the alveolar tissue. Moreover, exacerbations accelerate progression and challenge even more the management of COPD. Mechanisms of inflammation in COPD have been investigated over the past years, thus opening new avenues to develop novel targeted-directed therapies. Special attention has been paid to IL-33 and its receptor ST2, as they have been found to mediate immune responses and alveolar damage, and their expression is upregulated in COPD patients, which correlates with disease progression. Here we summarize the current knowledge on the IL-33/ST2 pathway and its involvement in COPD, with a special focus on developed antibodies and the ongoing clinical trials using anti-IL-33 and anti-ST2 strategies in COPD patients.

Verified
Journal Article
Open access
PDF file
LCLaura Cànaves-Gómez
Laura Cànaves-Gómez
AFAarne Fleischer
Aarne Fleischer
JMJosep Muncunill-Farreny
Josep Muncunill-Farreny
PCPaloma Giménez Carrero
Paloma Giménez Carrero
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
AFAlberto Alonso Fernandez
Alberto Alonso Fernandez
Obstructive sleep apnea (OSA) is quite prevalent during pregnancy and is associated with adverse perinatal outcomes, but its potential influence on fetal development remains unclear. This study investigated maternal OSA impact on the fetus by analyzing gene expression profiles in whole cord blood (WCB). Ten women in the third trimester of pregnancy were included, five OSA and five non-OSA cases. WCB RNA expression was analyzed by microarray technology to identify differentially expressed genes (DEGs) under OSA conditions. After data normalization, 3238 genes showed significant differential expression under OSA conditions, with 2690 upregulated genes and 548 downregulated genes. Functional enrichment was conducted using gene set enrichment analysis (GSEA) applied to Gene Ontology annotations. Key biological processes involved in OSA were identified, including response to oxidative stress and hypoxia, apoptosis, insulin response and secretion, and placental development. Moreover, DEGs were confirmed through qPCR analyses in additional WCB samples (7 with OSA and 13 without OSA). This highlighted differential expression of several genes in OSA (EGR1, PFN1 and PRKAR1A), with distinct gene expression profiles observed during rapid eye movement (REM)-OSA in pregnancy (PFN1, UBA52, EGR1, STX4, MYC, JUNB, and MAPKAP). These findings suggest that OSA, particularly during REM sleep, may negatively impact various biological processes during fetal development.

Verified
Journal Article
Open access
PDF file
LCLaura Cànaves-Gómez
Laura Cànaves-Gómez
PCPaloma Giménez Carrero
Paloma Giménez Carrero
ALAinhoa Alvarez Ruiz de Larrinaga
Ainhoa Alvarez Ruiz de Larrinaga
ABAndrés Sánchez Baron
Andrés Sánchez Baron
MMMercedes Codina Marcet
Mercedes Codina Marcet
AFAlberto Alonso Fernandez
Alberto Alonso Fernandez
Obstructive sleep apnea (OSA) is common during pregnancy and linked to adverse outcomes. While oxidative stress is a proposed pathogenic mechanism, evidence in pregnant populations remains limited. This multicenter, prospective study evaluated oxidative stress through protein carbonyl levels in 171 pregnant women and 86 cord blood samples. Polysomnography (PSG) performed during pregnancy categorized participants with the apnea–hypopnea index (AHI) in OSA, rapid eye movement (REM) OSA, and supine OSA. Protein carbonyl levels were measured by the dinitrophenyl hydrazine (DNPH) method. No significant differences were found in maternal or cord blood protein carbonyl levels between OSA and non-OSA groups, or between REM and supine OSA subgroups. Interestingly, women with shorter apnea–hypopnea (AH) length showed both higher maternal and cord blood protein carbonyl levels and lower nocturnal oxygen saturation. Overall, OSA in pregnancy was not associated with increased oxidative stress as measured by protein carbonyl levels. However, apnea–hypopnea duration and nocturnal hypoxia may influence oxidative stress, pointing to a complex relationship between OSA and oxidative stress during pregnancy, beyond traditional metrics like AHI. Future studies should explore additional biomarkers and diverse molecular pathways that could play a role, with special attention to emerging factors such as apnea–hypopnea length and hypoxic burden to elucidate the interrelationships between OSA and pregnancy more comprehensively.

Verified
Journal Article
Open access
PDF file
CSCarla Suarez-Castillejo
Carla Suarez-Castillejo
NCNéstor Calvo
Néstor Calvo
LPLuminita Preda
Luminita Preda
RDRocío Córdova Díaz
Rocío Córdova Díaz
NTNuria Toledo-Pons
Nuria Toledo-Pons
AFAlberto Alonso Fernandez
Alberto Alonso Fernandez
Although pulmonary embolism (PE) is a frequent complication in COVID-19, its consequences remain unknown. We performed pulmonary function tests, echocardiography and computed tomography pulmonary angiography and identified blood biomarkers in a cohort of consecutive hospitalized COVID-19 patients with pneumonia to describe and compare medium-term outcomes according to the presence of PE, as well as to explore their potential predictors. A total of 141 patients (56 with PE) were followed up during a median of 6 months. Post-COVID-19 radiological lung abnormalities (PCRLA) and impaired diffusing capacity for carbon monoxide (DLCOc) were found in 55.2% and 67.6% cases, respectively. A total of 7.3% had PE, and 6.7% presented an intermediate–high probability of pulmonary hypertension. No significant difference was found between PE and non-PE patients. Univariate analysis showed that age > 65, some clinical severity factors, surfactant protein-D, baseline C-reactive protein, and both peak red cell distribution width and Interleukin (IL)-10 were associated with DLCOc < 80%. A score for PCRLA prediction including age > 65, minimum lymphocyte count, and IL-1β concentration on admission was constructed with excellent overall performance. In conclusion, reduced DLCOc and PCRLA were common in COVID-19 patients after hospital discharge, but PE did not increase the risk. A PCRLA predictive score was developed, which needs further validation.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
LCLaura Cànaves-Gómez
Laura Cànaves-Gómez
AFAarne Fleischer
Aarne Fleischer
JMJosep Muncunill
Josep Muncunill
PGPaloma Gimenez
Paloma Gimenez
ACAmanda Iglesias Coma
Amanda Iglesias Coma
AFAlberto Alonso Fernández
Alberto Alonso Fernández
OSA is common during pregnancy and is associated with adverse perinatal consequences, but it is unknown whether it can also modulate fetal developmental processes. We studied the impact of maternal OSA by analyzing gene expression in whole cord blood (WCB). Methods: We included 10 women in the 3rd trimester of pregnancy (5 OSA and 5 Non-OSA). WCB RNA expression was analyzed by microarrays. Differentially expressed genes (DEG) were identified by differential expression analysis. Functional enrichment was performed by gene set enrichment analysis (GSEA) in Gene Ontology. Confirmation of DEG was carried out by q-PCR in an additional sample (7 OSA and 13 Non-OSA). Results: We found 3238 genes significantly differentially expressed after normalizing the data, with 2690 genes overexpressed and 548 genes under expressed. The most significant biological processes after GSEA analysis were response to oxidative stress and hypoxia, insulin response and secretion, placental development, and endothelial cell migration. Confirmation by qPCR showed differentially expression of EGR1, PFN1 and PRKAR1A genes in OSA. Furthermore, the expression of PFN1, UBA52, EGR1, STX4, MYC, JUNB and MAPKAP1 WCB genes were significantly different when women had OSA during REM sleep time. All these genes are implicated in the response to oxidative stress and hypoxia, as well as in insulin response and secretion, and placental development. Conclusion: FWCB showed different gene expression profile depending on the presence of OSA and OSA during REM during pregnancy, which could potentially have a negative influence on several biological processes during fetal development.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
LCLaura Cànaves-Gómez
Laura Cànaves-Gómez
PCPaloma Gimenez Carrero
Paloma Gimenez Carrero
AIAmanda Iglesias
Amanda Iglesias
ALAinhoa Alvarez Ruiz De Larrinaga
Ainhoa Alvarez Ruiz De Larrinaga
ABAndrés Sanchez Baron
Andrés Sanchez Baron
AFAlberto Alonso Fernandez
Alberto Alonso Fernandez
Obstructive sleep apnea (OSA) is prevalent in pregnancy, and it is associated with adverse pregnancy-related outcomes such as gestational diabetes mellitus (GDM). Oxidative stress is proposed to be one of the main intermediate mechanisms. However, the effects of OSA on systemic oxidative stress are unknown in pregnancy. Methods: Women with normal pregnancy and with GDM in the 3rd trimester underwent hospital polysomnography to evaluate whether OSA increases oxidative stress. OSA was defined as an apnea–hypopnea index (AHI) ≥5 h-1. Serum from women and from cord blood was collected to determine protein carbonyl by the 2,4-dinitro-phenyl-hydrazine method. Results: 171 women were included with a median age of 34 years. The pregestational body mass index (BMI) was 23.2 (21-26.6) Kg/m2. OSA was found in 28 patients ((AHI 7.8 (5.9-10.1) h-1)), who were older and had higher BMI than 143 women with AHI<5 h-1. Protein carbonyl concentrations were not different according to OSA (AHI≥5 h-1), to REM-OSA (REM-AHI≥5 h-1), or to supine-OSA (supine- AHI≥5 h-1). After delivery, 86 cord blood samples were collected. No differences were found in protein carbonyl based on the presence of different criteria of OSA. Similar results were found in the sub-analysis of both normal pregnant women and GDM. However, we found significant correlations between mean obstructive apneas length and maternal and fetal protein carbonyl (r=-0.37 and r=-0.58, respectively). Conclusions: OSA in the 3rd trimester was not associated with higher protein carbonyl levels both in pregnant women and in cord blood samples. However, obstructive apneas length showed a significant relationship.